$70.00 Original price was: $70.00.$9.00Current price is: $9.00.
By Adam Todd
Introduction
A unique text that integrates the basic science and clinical applications of anticancer agents, aimed at both undergraduate and postgraduate readers. This book provides a fully-integrated presentation of all aspects of the science of anticancer drugs, including their chemistry, pharmacology, and clinical applications.
Cancer: A Leading Cause of Death Worldwide
After heart disease, cancer is the number one killer worldwide, and the tumor microenvironment is forever changing, creating an ever-greater demand for safer, more effective anticancer agents. In response to that demand, the $100 billion cancer drug market continues to grow, with our increased understanding of cancer leading to new drugs being used clinically almost every year.
Book Structure
Anticancer Therapeutics is divided into three sections. Section 1 is an introduction to cancer and therapeutics, and covers the etiology and cellular and molecular basis of cancer. In Section 2, the authors focus on the anticancer agents – their discovery, synthesis, mode of action, mechanisms of resistance, and adverse reactions. Section 3 focuses on specific cancers, explaining how and why the various agents discussed in Section 2 are used, both individually and in combination, to treat different cancers.
Key Features
Target Audience
This book is an ideal textbook for undergraduates studying medicine, nursing, medicinal chemistry, pharmacy, pharmacology, and other allied health/life sciences. It is also a valuable bench reference for pharmacists, medics, and pharmaceutical researchers working in both academia and industry.
Publication Details
Anticancer Therapeutics is published by Wiley, with the first edition released on January 29, 2018. The book contains 326 pages and is available in English. The ISBN-10 is 1118622111, and the ISBN-13 is 978-1118622117.
Author |
---|
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline